Education / Career
| Article | Neutrophil to lymphocyte ratio improves prognostic prediction of international prognostic index for patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphaide, doxorubicin, vincristine and prednisone | ||
|---|---|---|---|
| Announcements | Leuk Lymphoma | Date of publication | 2015.07 |
| Co-researcher | |||
| Article | Total costs and clinical outcome of hematopoietic stem cell transplantation in adults with leukemia: comparison between reduced-intensity and myeloablative conditioning | ||
|---|---|---|---|
| Announcements | Clin Transplant | Date of publication | 2015.02 |
| Co-researcher | |||
| Article | Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era. | ||
|---|---|---|---|
| Announcements | Cancer Res Treat | Date of publication | 2016.01 |
| Co-researcher | |||
| Article | A rare case of Rosai-Dorfman disease without lymphadenopathy | ||
|---|---|---|---|
| Announcements | Korean J Intern Med | Date of publication | 2016.07 |
| Co-researcher | |||
| Article | Therapeutic implication of HER2 in advanced biliary tract cancer | ||
|---|---|---|---|
| Announcements | Oncotarget | Date of publication | 2016.09 |
| Co-researcher | |||
| Article | Soluble programmed death-ligand 1(sPDL1) and neutrophil-to-lymphocyte ratio(NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy | ||
|---|---|---|---|
| Announcements | Oncotarget | Date of publication | 2016.11 |
| Co-researcher | |||
| Article | Survival outcomes according to adjuvant treatment and prognostic factors including host immune markers in patients with curatively resected ampulla of vater cancer | ||
|---|---|---|---|
| Announcements | PLoS One | Date of publication | 2016.04 |
| Co-researcher | |||